# A Clinical Study to Evaluate the Pharmacokinetics and Bioequivalence of HMPL-523 Tablets Produced by Two Different Manufacturers

> **NCT05318820** · EARLY_PHASE1 · COMPLETED · sponsor: **Hutchison Medipharma Limited** · enrollment: 39 (actual)

## Conditions studied

- Healthy Subject

## Interventions

- **DRUG:** HMPL-523

## Key facts

- **NCT ID:** NCT05318820
- **Lead sponsor:** Hutchison Medipharma Limited
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-01
- **Primary completion:** 2022-07-31
- **Final completion:** 2022-09-30
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2023-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05318820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05318820, "A Clinical Study to Evaluate the Pharmacokinetics and Bioequivalence of HMPL-523 Tablets Produced by Two Different Manufacturers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05318820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*